Transplantation of embryonic porcine mesencephalic tissue in patients with PD

Neurology

Volumn 54, Issue 5, 2000, Pages 1042-1050

  Schumacher, J M ^b,f   Ellias, Samuel A ^a,h   Palmer, E P ^b   Kott, H S ^b   Dinsmore, J ^c   Dempsey, P K ^b   Fischman, A J ^d   Thomas, C ^a   Feldman, R G ^a   Kassissieh, S ^b   Raineri, R ^e   Manhart, C ^e   Penney, D ⁱ   Fink, J S ^d,g   Isacson, O ^d,f  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b GENVEC INC   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Primedica Corporation   (United States)

^e MCLEAN HOSPITAL   (United States)

^f GENZYME CORPORATION   (United States)

^g Neurological Associates   (United States)

^h BOSTON MEDICAL CENTER   (United States)

ⁱ NONE

Author keywords

Embryonic cell transplant; Monoclonal antibody; PD; Porcine retrovirus; Xenotransplant

Indexed keywords

BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CYCLOSPORIN; LEVODOPA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PERGOLIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EMBRYONAL TISSUE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

EID: 17544400499     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.5.1042     Document Type: Article

References (38)

1. Bjorklund A, Stenevi U. Reconstruction of the nigrostriatal pathway by intracerebral nigral transplants. Brain Res 1979; 177:555-560.
2. Brundin P, Strecker R, Widner H, et al. Human embryonic dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behavior, and dopamine release. Exp Brain Res 1988;70:192-208.
3. Lindvall O, Rehncrona S, Gustuvii B, et al. Embryonic dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 1988;2:1483-1484.
4. Freeman T, Olanow C, Hauser R, et al. Bilateral embryonic nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38:379-388.
5. Defer G, Geny C, Ricolfi F, et al. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 1996;119:410-450.
6. Wenning G, Odin P, Morrish P, et al. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997;42:95-107.
7. Widner H, Tetrud J, Rehncrona S, et al. Bilateral embryonic mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 1992;237:1556-1563.
8. Kordower J, Freeman T, Snow B, et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of embryonic mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 1995;332:1118-1124.
9. Hauser RA, Freeman TB, Snow BJ, et al. Long-term evaluation of bilateral embryonic nigral transplantation in Parkinson disease. Arch Neurol 1999;56:179-187.
10. Greenley HT, Hamm T, Johnson R, Price CR, Weingarten R, Raffin T. The ethical use of human embryonic tissue in medicine. N Engl J Med 1989;320:1093-1096.
11. Dunning J, White D, Wallwork J. The rationale for xenotransplantation as a solution to the donor organ shortage. Pathol Biol 1994;42:231-235.
12. Freeman TB, Wojak J, Brandeis L, Michel J, Pearson J, Flamm E. Cross-species intracerebral grafting of embryonic swine dopaminergic neurons. Prog Brain 1988;78:473-477.
13. Isacson O, Deacon TW, Pakzaban P, Galpern WR, Dinsmore J, Burns LH. Transplanted xenogeneic neural cells in neuro-degenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nat Med 1995;11:1189-1194.
14. Galpern WR, Burns LH, Deacon TW, Dinsmore J, Isacson O. Xenotransplantation of porcine embryonic ventral mesencephalon in a rat model of Parkinson's disease: functional recovery and graft morphology. Exp Neurol 1996;140:1-13.
15. Chapman L, Folks T, Salomon D, Patterson A, Eggerman T, Noguchi P. Xenotransplantation and xenogenic infections. N Engl J Med 1995;333:1498-1501.
16. Patience C, Takeuchi Y, Weiss R. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997;3:282-286.
17. Langston J, Widner H, Goetz C, et al. Core Assessment Program for Intracerebral Transplantation (CAPIT). Mov Disord 1992;7:2-13.
18. Fahn S, Elton R. The Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease. Macmillan Healthcare Information 1987;2:153-163, 293-304.
19. Pakazaban P, Deacon T, Burns L, Dinsmore J, Isacson O. A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 1995;65:983-996.
20. Faustman D, Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991;252:1700-1702.
21. United States Department of Health and Human Services. Draft public health service guideline on infectious disease issues in Xenotransplantation. Washington, DC: 1996.
22. 18F]fluoro-L-dopa for human studies with PET. Appl Radiat Isot 1990;41:275-281.
23. Deacon T, Schumacher J, Dinsmore J, et al. Histological evidence of embryonic pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997;3: 350-353.
24. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-1042.
25. Freed C, Breeze R, Rosenberg N, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 1992;237:1549-1555.
26. Lindvall O, Rehncrona S, Brundin P, et al. Human embryonic dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease: a detailed account of methodology and a 6-month follow-up. Arch Neurol 1989;46:615-631.
27. Lindvall O, Brundin P, Widner H, et al. Grafts of fetal dopamine neurons survive and improve motor functions in Parkinson's disease. Science 1990;247:574-577.
28. Fahn S, Greene P, Tsai W, et al. Double-blind controlled trial of human embryonic dopaminergic tissue transplants in advanced Parkinson's disease: clinical outcomes. Neurology 1999;52:A405. Abstract.
29. Borlongan CV, Freeman TB, Scorcia TA, et al. Cyclosporine-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats. Cell Transplant 1995;4:65-72.
30. 18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995;38:580-588.
31. Snow B. PET studies of transplantation therapy. In: Freeman TB, Widner H, eds. Cell transplantation for neurological disorders. Totowa, NJ: Humana Press, 1998:45-48.
32. Platt JL, Lin SS. The future promises of Xenotransplantation. Ann NY Acad Sci 1998;862:5-18.
33. Boonman Z, Isacson O. Apoptosis in neuronal development and transplantation: role of caspases and trophic factors. Exp Neurol 1999;156:1-15.
34. Osorio R, Ascher N, Stock P. Prolongation of in vivo mouse islet allograft survival by modulation of MHC class I antigen. Transplantation 1994;57:783-788.
35. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999;285:1236-1241.
36. Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998;352:695-698.
37. Patience C, Patton G, Takeuchi Y, et al. No evidence of pig DNA or retroviral infection in patients with short-term extra-corporeal connection to pig kidneys. Lancet 1998;352:699-701.
38. Saint-Hilaire M, Shannon K, Schumacher J, et al. Transplantation of embryonic porcine striatal cells in Huntington's disease: preliminary safety and efficacy results. Neurology 1998; 50:A80-A81. Abstract.